大动脉炎患者的心血管危险因素分析
Cardiovascular Risk Factors in Patients with Takayasu Arteritis
摘要: 大动脉炎(Takayasu’s Arteritis, TA)是一种主要累及大动脉及其主要分支的慢性系统性血管炎，主要表现为血管的狭窄和炎性闭塞，也可因炎症侵及血管壁中层导致血管扩张或动脉瘤。其中有不在少数的TA患者以冠状动脉受累导致心肌缺血，完善影像学检查发现冠状动脉开口和近端节段血管最常受累，此类患者易发生猝死或广泛心肌梗死。因此，研究TA患者相关的心血管危险因素，对于该疾病的预防和治疗有重要的意义。
Abstract: Takayasu’s Arteritis (TA) is a chronic systemic vasculitis mainly involving large arteries and their main branches. It is mainly manifested by vascular stenosis and inflammatory occlusion, and can also lead to vascular dilatation or aneurysm due to inflammation invading the middle layer of the vascular wall. Coronary artery involvement leads to myocardial ischemia in more than a small number of TA patients. Imaging findings show that coronary artery openings and proximal segment are most frequently involved, which are prone to sudden death or extensive myocardial infarction. Therefore, the study of cardiovascular risk factors in patients with TA is of great significance for the prevention and treatment of this disease.
文章引用：崔明丽, 李洋, 刁树玲, 张贝, 丁法明, 徐会圃, 程艳丽. 大动脉炎患者的心血管危险因素分析[J]. 临床医学进展, 2023, 13(1): 765-771. https://doi.org/10.12677/ACM.2023.131111

参考文献

[1] Kerr, G.S, Hallahan, C.W., Giordano, J., et al. (1994) Takayasu Arteritis. Annals of Internal Medicine, 120, 919-929. [Google Scholar] [CrossRef] [PubMed]
[2] Subramanyan, R., Joy, J. and Balakrishnan, K.G. (1989) Natural History of Aortoarteritis (Takayasu’s Disease). Circulation, 80, 429-437. [Google Scholar] [CrossRef] 
[3] Alibaz-Oner, F., Koster, M.J., Unal, A.U., et al. (2017) Assessment of the Frequency of Cardiovascular Risk Factors in Patients with Takayasu’s Arteritis. Rheumatology (Oxford), 56, 1939-1944. [Google Scholar] [CrossRef] [PubMed]
[4] Egebjerg, K., Baslund, B., Obel, N. and Faurschou, M. (2020) Mortality and Cardiovascular Morbidity among Patients Diagnosed with Takayasu’s Arteritis: A Danish Nationwide Cohort Study. Clinical and Experimental Rheumatology, 124, 91-94.
[5] Rav-Acha, M., Plot, L., Peled, N., et al. (2007) Coronary Involvement in Takayasu’s Arteritis. Autoimmunity Reviews, 6, 566-571. [Google Scholar] [CrossRef] [PubMed]
[6] Endo, M., Tomizawa, Y., Nishida, H., et al. (2003) Angiographic Findings and Surgical Treatments of Coronary Artery Involvement in Takayasu Arteritis. The Journal of Thoracic and Cardiovascular Surgery, 125, 570-577. [Google Scholar] [CrossRef] [PubMed]
[7] Sun, T., Zhang, H., Ma, W., et al. (2013) Coronary Artery Involvement in Takayasu Arteritis in 45 Chinese Patients. The Journal of Rheumatology, 40, 493-497. [Google Scholar] [CrossRef] [PubMed]
[8] Zhou, S., Gao, C. and Li, F. (2021) Acute Myocardial Infarction with Left Main Coronary Artery Ostial Negative Remodelling as the First Manifestation of Takayasu Arteritis: A Case Report. BMC Cardiovascular Disorders, 21, Article 560. [Google Scholar] [CrossRef] [PubMed]
[9] Zhang, T., Peng, B., Tu, X., et al. (2019) Acute Myocardial Infarction as the First Manifestation of Takayasu Arteritis: A Case Re-port. Medicine (Baltimore), 98, e15143. [Google Scholar] [CrossRef] 
[10] Mihailovici, A.R., Donoiu, I., Istratoaie, O., et al. (2018) A Case of Severe Advanced Takayasu Arteritis with Acute Myocardial Infarction as First Manifestation. Current Health Sciences Journal, 44, 80-84.
[11] Downs, J.R., Clearfield, M., Weis, S., et al. (1998) Primary Prevention of Acute Coronary Events with Lovastatin in Men and Women with Average Cholesterol Levels: Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA, 279, 1615-1622. [Google Scholar] [CrossRef] [PubMed]
[12] De Carvalho, J.F., Bonfa, E., Bezerra, M.C., et al. (2009) High Frequency of Lipoprotein Risk Levels for Cardiovascular Disease in Takayasu Arteritis. Clinical Rheuma-tology, 28, 801-805. [Google Scholar] [CrossRef] [PubMed]
[13] Wang, X., Chen, B., Lv, N., et al. (2015) Association of Abnor-mal Lipid Spectrum with the Disease Activity of Takayasu Arteritis. Clinical Rheumatology, 34, 1243-1248. [Google Scholar] [CrossRef] [PubMed]
[14] Chen, S., Luan, H., He, J., et al. (2020) The Relationships of Se-rum Homocysteine Levels and Traditional Lipid Indicators with Disease Activity and Coronary Artery Involvement in Takayasu Arteritis. Immunologic Research, 68, 405-413. [Google Scholar] [CrossRef] [PubMed]
[15] Da Silva, T.F., Levy-Neto, M., Bonfa, E., et al. (2013) High Prevalence of Metabolic Syndrome in Takayasu Arteritis: Increased Cardiovascular Risk and Lower Adiponectin Serum Levels. The Journal of Rheumatology, 40, 1897-1904. [Google Scholar] [CrossRef] [PubMed]
[16] Vargas-Hitos, J.A., Jimenez-Jaimez, J., Molina Navarro, E., et al. (2019) Takayasu Arteritis, Malignant Hypertension and Severe Left Ventricular Hypertrophy. International Journal of Rheumatic Diseases, 22, 951-955. [Google Scholar] [CrossRef] 
[17] Patel, B., Tiwari, A., Dubey, S.R., et al. (2017) Takayasu Arteritis Presenting with Malignant Hypertension; A Rare Manifestation of a Rare Disease: A Case Report and Review of the Lit-erature. Tropical Doctor, 47, 60-63. [Google Scholar] [CrossRef] [PubMed]
[18] Qi, Y., Yang, L., Zhang, H., et al. (2018) The Presentation and Management of Hypertension in a Large Cohort of Takayasu Arteritis. Clinical Rheumatology, 37, 2781-2788. [Google Scholar] [CrossRef] [PubMed]
[19] Saglam, B., Kaymaz-Tahra, S., Kenar, G., et al. (2022) Metabolic Syndrome Is Associated with Increased Cardiovascular Risk and Disease Damage in Patients with Takayasu Arteritis. International Journal of Rheumatic Diseases, 25, 775-780. [Google Scholar] [CrossRef] 
[20] Mauricio, D., Corcoy, R., Morales, J., et al. (2000) Association of Takayasu’s Disease and Autoimmune Gestational Diabetes Mellitus. Endocrine Journal, 47, 203-204. [Google Scholar] [CrossRef] [PubMed]
[21] Bulum, J., Car, N., Smircic-Duvnjak, L., et al. (2005) Takayasu’s Ar-teritis and Chronic Autoimmune Thyroiditis in a Patient with Type 1 Diabetes Mellitus. Clinical Rheumatology, 24, 169-171. [Google Scholar] [CrossRef] [PubMed]
[22] Soto, M.E., Melendez-Ramirez, G., Kimura-Hayama, E., et al. (2011) Coronary CT Angiography in Takayasu Arteritis. JACC Cardiovasc Imaging, 4, 958-966. [Google Scholar] [CrossRef] [PubMed]
[23] Du, J., Ren, Y., Liu, J., et al. (2022) Association of Prolonged Disease Duration and TG/HDL-C Ratio in Accelerating Atherosclerosis in Patients with Takayasu’s Arteritis. Clinical and Applied Thrombosis/Hemostasis, 28, Article ID：10760296221121297. [Google Scholar] [CrossRef] [PubMed]
[24] Wang, Y., Jia, S.J., Zhou, Y., et al. (2020) A Study on the Risk Factors of Coronary Artery Disease in Patients with Takayasu Arteritis. Journal of Thoracic Disease, 12, 2031-2038. [Google Scholar] [CrossRef] [PubMed]
[25] Bikle, D.D. (2007) What Is New in Vitamin D: 2006-2007. Current Opinion in Rheumatology, 19, 383-388. [Google Scholar] [CrossRef] 
[26] Sassi, F., Tamone, C. and D’Amelio, P. (2018) Vitamin, D: Nutrient, Hormone, and Immunomodulator. Nutrients, 10, Article 1656. [Google Scholar] [CrossRef] [PubMed]
[27] Hewison, M. (2012) Vitamin D and Immune Function: Autocrine, Para-crine or Endocrine? Scandinavian Journal of Clinical and Laboratory Investigation, 243, 92-102.
[28] Pike, J.W. and Meyer, M.B. (2010) The Vitamin D Receptor: New Paradigms for the Regulation of Gene Expression by 1,25-Dihydroxyvitamin D3. Endocrinology and Metabolism Clinics of North America, 39, 255-269. [Google Scholar] [CrossRef] [PubMed]
[29] Ellison, T.I., Dowd, D.R. and Macdonald, P.N. (2005) Calmodu-lin-Dependent Kinase IV Stimulates Vitamin D Receptor-Mediated Transcription. Molecular Endocrinology, 19, 2309-2319. [Google Scholar] [CrossRef] [PubMed]
[30] Chen, S., Law, C.S., Grigsby, C.L., et al. (2011) Cardio-myocyte-Specific Deletion of the Vitamin D Receptor Gene Results in Cardiac Hypertrophy. Circulation, 124, 1838-1847. [Google Scholar] [CrossRef] 
[31] Hellmann, D.B., Grand, D.J. and Freischlag, J.A. (2007) Inflammatory Abdominal Aortic Aneurysm. JAMA, 297, 395-400. [Google Scholar] [CrossRef] [PubMed]
[32] Gatenby, P.A., Lucas, R.M., Engelsen, O., et al. (2009) Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: Could Geographic Patterns Be Explained by Ambient Ultraviolet Radia-tion? Arthritis and Rheumatism, 61, 1417-1424. [Google Scholar] [CrossRef] [PubMed]
[33] Welsh, P., Peters, M.J., Mcinnes, I.B., et al. (2011) Vitamin D Deficiency Is Common in Patients with RA and Linked to Disease Activity, but Circulating Levels Are Unaffected by TNFalpha Blockade: Results from a Prospective Cohort Study. Annals of Rheumatic Diseases, 70, 1165-1167. [Google Scholar] [CrossRef] [PubMed]
[34] Mceniery, C.M. and Wilkinson, I.B. (2005) Large Artery Stiffness and Inflammation. Journal of Human Hypertension, 19, 507-509. [Google Scholar] [CrossRef] [PubMed]
[35] Maki-Petaja, K.M. and Wilkinson, I.B. (2009) Anti-Inflammatory Drugs and Statins for Arterial Stiffness Reduction. Current Pharmaceutical Design, 15, 290-303. [Google Scholar] [CrossRef] [PubMed]
[36] Hollan, I., Meroni, P.L., Ahearn, J.M., et al. (2013) Cardio-vascular Disease in Autoimmune Rheumatic Diseases. Autoimmunity Reviews, 12, 1004-1015. [Google Scholar] [CrossRef] [PubMed]

为你推荐